Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Interest Coverage Ratio (2016 - 2019)

Vistagen Therapeutics (VTGN) has disclosed Interest Coverage Ratio for 8 consecutive years, with 3975.33 as the latest value for Q4 2019.

  • Quarterly Interest Coverage Ratio rose 199.49% to 3975.33 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was 10427.67 through Sep 2020, up 325.87% year-over-year, with the annual reading at 3069.54 for FY2019, 92.39% down from the prior year.
  • Interest Coverage Ratio hit 3975.33 in Q4 2019 for Vistagen Therapeutics, up from 347.47 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 3975.33 in Q4 2019 to a low of 8501.0 in Q1 2016.
  • Historically, Interest Coverage Ratio has averaged 1835.53 across 5 years, with a median of 1664.67 in 2017.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 40614.44% in 2016 and later skyrocketed 199.49% in 2019.
  • Year by year, Interest Coverage Ratio stood at 714.0 in 2015, then plummeted by 269.33% to 2637.0 in 2016, then surged by 45.62% to 1434.0 in 2017, then tumbled by 178.64% to 3995.72 in 2018, then skyrocketed by 199.49% to 3975.33 in 2019.
  • Business Quant data shows Interest Coverage Ratio for VTGN at 3975.33 in Q4 2019, 347.47 in Q3 2019, and 3995.72 in Q4 2018.